Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
Heron Therapeutics (HRTX) - Net assets
Net assets on the balance sheet as of December 2023 : -$33.98 M
According to Heron Therapeutics's latest financial reports the company has -$33.98 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Heron Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-33.98 M | -350.32% |
| 2022-12-31 | $13.57 M | -82.5% |
| 2021-12-31 | $77.57 M | -67.2% |
| 2020-12-31 | $0.23 B | -41.44% |
| 2019-12-31 | $0.40 B | 9.1% |
| 2018-12-31 | $0.37 B | 182.27% |
| 2017-12-31 | $0.13 B | -717.08% |
| 2016-12-31 | $-21.26 M | -117.99% |
| 2015-12-31 | $0.11 B | 87.29% |
| 2014-12-31 | $63.06 M | -8.53% |
| 2013-12-31 | $68.94 M | 33.05% |
| 2012-12-31 | $51.81 M | 228.96% |
| 2011-12-31 | $15.75 M | 1096.96% |
| 2010-12-31 | $1.31 M | -80.64% |
| 2009-12-31 | $6.79 M | -10.56% |
| 2008-12-31 | $7.59 M | -74.22% |
| 2007-12-31 | $29.47 M | 144.41% |
| 2006-12-31 | $12.05 M | 94.41% |
| 2005-12-31 | $6.2 M | -56.17% |
| 2004-12-31 | $14.15 M | 25.67% |
| 2003-12-31 | $11.26 M | -27.14% |
| 2002-12-31 | $15.45 M | -19.36% |
| 2001-12-31 | $19.17 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $0.12 B | -459.55% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.87 B | -2,661.24% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.70 B | -2,163.15% | 🇺🇸 USA |
 Alkermes ALKS | $1.20 B | -3,640.13% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.13 B | -485.56% | 🇺🇸 USA |